Annual FCF
-$76.89 M
-$34.68 M-82.17%
December 31, 2023
Summary
- As of February 7, 2025, SMMT annual free cash flow is -$76.89 million, with the most recent change of -$34.68 million (-82.17%) on December 31, 2023.
- During the last 3 years, SMMT annual FCF has fallen by -$28.36 million (-58.43%).
- SMMT annual FCF is now -610.35% below its all-time high of $15.07 million, reached on January 31, 2017.
Performance
SMMT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$30.36 M
+$2.71 M+8.20%
September 30, 2024
Summary
- As of February 7, 2025, SMMT quarterly free cash flow is -$30.36 million, with the most recent change of +$2.71 million (+8.20%) on September 30, 2024.
- Over the past year, SMMT quarterly FCF has increased by +$2.71 million (+8.20%).
- SMMT quarterly FCF is now -188.26% below its all-time high of $34.39 million, reached on October 31, 2016.
Performance
SMMT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$113.02 M
-$15.40 M-15.78%
September 30, 2024
Summary
- As of February 7, 2025, SMMT TTM free cash flow is -$113.02 million, with the most recent change of -$15.40 million (-15.78%) on September 30, 2024.
- Over the past year, SMMT TTM FCF has dropped by -$15.40 million (-15.78%).
- SMMT TTM FCF is now -487.28% below its all-time high of $29.18 million, reached on July 31, 2017.
Performance
SMMT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SMMT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.2% | +8.2% | -15.8% |
| 3 y3 years | -58.4% | -683.6% | -167.8% |
| 5 y5 years | -118.0% | -251.0% | -363.2% |
SMMT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.2% | at low | -683.6% | +8.2% | -213.7% | at low |
| 5 y | 5-year | -264.4% | at low | -683.6% | +8.2% | -365.3% | at low |
| alltime | all time | -610.4% | at low | -188.3% | +8.2% | -487.3% | at low |
Summit Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$30.36 M(-8.2%) | -$113.02 M(+15.8%) |
| Jun 2024 | - | -$33.06 M(+9.7%) | -$97.61 M(+4.0%) |
| Mar 2024 | - | -$30.14 M(+54.9%) | -$93.84 M(+22.1%) |
| Dec 2023 | -$76.89 M(+82.2%) | -$19.46 M(+30.2%) | -$76.89 M(+47.2%) |
| Sep 2023 | - | -$14.95 M(-49.0%) | -$52.23 M(+14.0%) |
| Jun 2023 | - | -$29.29 M(+122.2%) | -$45.81 M(+27.2%) |
| Mar 2023 | - | -$13.18 M(-353.5%) | -$36.03 M(-14.6%) |
| Dec 2022 | -$42.21 M(-42.1%) | $5.20 M(-160.9%) | -$42.21 M(-25.6%) |
| Sep 2022 | - | -$8.54 M(-56.3%) | -$56.71 M(-20.9%) |
| Jun 2022 | - | -$19.51 M(+0.8%) | -$71.73 M(+0.3%) |
| Mar 2022 | - | -$19.36 M(+108.2%) | -$71.55 M(-1.8%) |
| Dec 2021 | -$72.89 M(+50.2%) | -$9.30 M(-60.5%) | -$72.89 M(+1.8%) |
| Sep 2021 | - | -$23.56 M(+21.9%) | -$71.61 M(+10.6%) |
| Jun 2021 | - | -$19.32 M(-6.7%) | -$64.75 M(+1.0%) |
| Mar 2021 | - | -$20.71 M(+158.2%) | -$64.09 M(+32.1%) |
| Dec 2020 | -$48.53 M(+130.0%) | - | - |
| Dec 2020 | - | -$8.02 M(-51.9%) | -$48.53 M(+19.8%) |
| Sep 2020 | - | -$16.69 M(-10.6%) | -$40.51 M(+24.8%) |
| Jun 2020 | - | -$18.66 M(+262.2%) | -$32.47 M(+33.7%) |
| Mar 2020 | - | -$5.15 M(-40.4%) | -$24.29 M(-0.5%) |
| Dec 2019 | -$21.10 M(-40.2%) | - | - |
| Oct 2019 | - | -$8.65 M(-17.6%) | -$24.40 M(+19.3%) |
| Jul 2019 | - | -$10.49 M(-683.2%) | -$20.45 M(-14.2%) |
| Apr 2019 | - | $1.80 M(-125.5%) | -$23.85 M(-32.4%) |
| Jan 2019 | -$35.27 M(+65.9%) | - | - |
| Jan 2019 | - | -$7.06 M(+50.2%) | -$35.27 M(-5.2%) |
| Oct 2018 | - | -$4.70 M(-66.2%) | -$37.19 M(-19.7%) |
| Jul 2018 | - | -$13.89 M(+44.4%) | -$46.33 M(+129.0%) |
| Apr 2018 | - | -$9.62 M | -$20.23 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | -$21.26 M(-241.1%) | - | - |
| Jan 2018 | - | -$8.98 M(-35.1%) | -$21.26 M(+11.6%) |
| Oct 2017 | - | -$13.85 M(-213.4%) | -$19.05 M(-165.3%) |
| Jul 2017 | - | $12.21 M(-214.7%) | $29.18 M(+112.4%) |
| Apr 2017 | - | -$10.64 M(+57.1%) | $13.74 M(-8.8%) |
| Jan 2017 | $15.07 M(-161.3%) | - | - |
| Jan 2017 | - | -$6.78 M(-119.7%) | $15.07 M(+3.1%) |
| Oct 2016 | - | $34.39 M(-1163.1%) | $14.61 M(-155.7%) |
| Jul 2016 | - | -$3.23 M(-65.3%) | -$26.22 M(-6.0%) |
| Apr 2016 | - | -$9.32 M(+28.9%) | -$27.89 M(+13.6%) |
| Jan 2016 | -$24.56 M(+47.6%) | - | - |
| Jan 2016 | - | -$7.23 M(+12.2%) | -$24.56 M(+12.6%) |
| Oct 2015 | - | -$6.44 M(+31.3%) | -$21.81 M(+17.6%) |
| Jul 2015 | - | -$4.91 M(-18.0%) | -$18.55 M(-8.2%) |
| Apr 2015 | - | -$5.99 M(+33.6%) | -$20.19 M(+21.4%) |
| Jan 2015 | -$16.64 M(+70.5%) | - | - |
| Jan 2015 | - | -$4.48 M(+41.1%) | -$16.64 M(+36.8%) |
| Oct 2014 | - | -$3.17 M(-51.6%) | -$12.16 M(+35.3%) |
| Jul 2014 | - | -$6.55 M(+169.4%) | -$8.99 M(+269.4%) |
| Apr 2014 | - | -$2.43 M | -$2.43 M |
| Jan 2014 | -$9.76 M(+89.3%) | - | - |
| Jan 2013 | -$5.15 M(+29.1%) | - | - |
| Jan 2012 | -$3.99 M(-11.9%) | - | - |
| Jan 2011 | -$4.53 M(+62.6%) | - | - |
| Jan 2010 | -$2.79 M(-83.0%) | - | - |
| Jan 2009 | -$16.37 M(-18.1%) | - | - |
| Jan 2008 | -$19.99 M(+114.2%) | - | - |
| Jan 2007 | -$9.33 M(+128.8%) | - | - |
| Jan 2006 | -$4.08 M(-9520.3%) | - | - |
| Jan 2005 | $43.30 K | - | - |
FAQ
- What is Summit Therapeutics annual free cash flow?
- What is the all time high annual FCF for Summit Therapeutics?
- What is Summit Therapeutics annual FCF year-on-year change?
- What is Summit Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Summit Therapeutics?
- What is Summit Therapeutics quarterly FCF year-on-year change?
- What is Summit Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Summit Therapeutics?
- What is Summit Therapeutics TTM FCF year-on-year change?
What is Summit Therapeutics annual free cash flow?
The current annual FCF of SMMT is -$76.89 M
What is the all time high annual FCF for Summit Therapeutics?
Summit Therapeutics all-time high annual free cash flow is $15.07 M
What is Summit Therapeutics annual FCF year-on-year change?
Over the past year, SMMT annual free cash flow has changed by -$34.68 M (-82.17%)
What is Summit Therapeutics quarterly free cash flow?
The current quarterly FCF of SMMT is -$30.36 M
What is the all time high quarterly FCF for Summit Therapeutics?
Summit Therapeutics all-time high quarterly free cash flow is $34.39 M
What is Summit Therapeutics quarterly FCF year-on-year change?
Over the past year, SMMT quarterly free cash flow has changed by +$2.71 M (+8.20%)
What is Summit Therapeutics TTM free cash flow?
The current TTM FCF of SMMT is -$113.02 M
What is the all time high TTM FCF for Summit Therapeutics?
Summit Therapeutics all-time high TTM free cash flow is $29.18 M
What is Summit Therapeutics TTM FCF year-on-year change?
Over the past year, SMMT TTM free cash flow has changed by -$15.40 M (-15.78%)